APYX Stock Analysis: Buy, Sell, or Hold?
APYX - Apyx Medical Corporation Common Stock
$3.79
-0.06 (-1.56%)
▼
5d:
-2.82%
30d:
+32.98%
90d:
+14.85%
BUY
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Get Alerted When APYX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: APYX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: APYX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: APYX is currently trading at $3.79, which is considered fair relative to its 30-day fair value range of $3.33 to $4.16.
Technical Outlook: Technically, APYX is showing sideways momentum. The price is currently testing key support at $3.74. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.50 (+71.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, APYX is showing sideways momentum. The price is currently testing key support at $3.74. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.50 (+71.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.33 -
$4.16
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 71.5% below Wall St target ($6.50)
Trading Range Analysis
30-Day Trading Range
$3.33 -
$4.16
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.74
Resistance Level
$4.40
Current Trend
Sideways
Technical data as of
Jun 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-14.44
Wall Street Target
$6.50
(+71.5%)
Revenue Growth (YoY)
32.5%
Profit Margin
-16.4%
Share & Embed Analysis
Last updated: June 03, 2026 5:08 PM ET
Data refreshes hourly during market hours. Next update: 6:08 PM
Data refreshes hourly during market hours. Next update: 6:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APYX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$83 | 54 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 64 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$389 | 49 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$247 | 62 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$107 | 61 BUY |
